PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey

(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.

############

Story Source: Materials provided by Scienmag

PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey

Related Posts

CREW Web Program Feasible for Women’s Cardiac Rehabilitation in Rural, Remote Communities

Laser Therapy Shows Promise Against Deadly Brain Tumors

Engineered Bacteria Mimic Organelles, Restore PTEN and p53, Fight Cancer

Real-world study confirms TB preventive treatment works for people with HIV

POPULAR NEWS

CREW Web Program Feasible for Women’s Cardiac Rehabilitation in Rural, Remote Communities

One in 20 Australian women now receive intravenous iron infusions

Smartphones, Online Music Streaming, and Traffic Fatalities Linked in New Study

Integrated data and machine learning transform lung cancer diagnosis and treatment

About

Follow us

Recent News

CREW Web Program Feasible for Women’s Cardiac Rehabilitation in Rural, Remote Communities

One in 20 Australian women now receive intravenous iron infusions

Smartphones, Online Music Streaming, and Traffic Fatalities Linked in New Study

Subscribe to Blog via Email

Welcome Back!

Retrieve your password